Denver Dale

Denver Dale, Ph.D. is the founder and CEO of On-Point Capital LLC, an investment management firm that provides highly specialized investment services to a select group of significant investors. In this capacity, Denver sets overall strategy for the firm and leads investment platform design, development and execution. OPC is currently launching a series of expert venture capital funds focused at the intersection of Synthetic Biology and major industrial sectors such as Energy-Resources, Agriculture-Food, Industrial Chemicals-Materials, Water-Cleantech and Medicine-Healthcare. OPC’s platform has been carefully designed to provide significant investors with a customized vehicle through which to both support and participate in the enormous human- and economic potential of Synthetic Biology. Prior to forming OPC, Denver ran an elite investment unit within Goldman Sachs & Co. directly managing more than US$4 billion on behalf of a small number of significant investors. In addition, Denver has been the founder and CFO of several technology-enabled businesses where he designed and managed global operations, investor relations, client services and business development. Denver has a Ph.D. in biomedical sciences from Oxford University and a B.Sc. (Hons) in medical and marine biology from the University of Queensland, Australia.